Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated (RB SFCE 2009)
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 125
Summary
- Conditions
- Retinoblastoma
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: Non-RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Younger than 210 years
- Gender
- Both males and females
Description
Post operative chemotherapy +/- radiotherapy according to histopathological risk factors of the International Retinoblastoma Staging Working Group. Low risk group : No optic nerve involvement. Intra and prelaminar involvement No choroidal involvement. Minimal superficial choroidal involvement . Inte...
Post operative chemotherapy +/- radiotherapy according to histopathological risk factors of the International Retinoblastoma Staging Working Group. Low risk group : No optic nerve involvement. Intra and prelaminar involvement No choroidal involvement. Minimal superficial choroidal involvement . Intermediate risk group, 2 sub groups : Sub group 1 : Retrolaminar involvement without Invasion of surgical margin associated or not to massive choroidal involvement Anterior segment involvement. Intrascleral involvement. Sub Group 2 : Isolated massive choroidal involvement. High risk group : Invasion of the surgical margin of the optic nerve and/or microscopic extrascleral involvement Optic nerve meningeal sheat involvement .
Tracking Information
- NCT #
- NCT02870907
- Collaborators
- Not Provided
- Investigators
- Not Provided
Get Well Soon